Treatment Set Ts344570
Product Images NDC 49288-0837

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Treatment Set Ts344570 (NDC 49288-0837). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Antigen Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mL Rx Set Label (10mlrxsetlabel)

Treatment Set TS344570 allergenic extract label from Antigen Laboratories, Inc. The label includes instructions for subcutaneous initial dosing, refrigeration requirements, and warnings for physician use only. It emphasizes not dispensing without prescription and notes the U.S. government license and non-returnable status.*

FDA Label Image

5 mL Rx Set Label (5mlrxsetlabel)

Packaging label for Treatment Set TS344570 by Antigen Laboratories, Inc. The label identifies the product as an allergenic extract, specifying an initial dose of 0.10 ml subcutaneously. It includes standard warnings, a caution about prescription use, and storage instructions to refrigerate between 2°-8° Celsius. The label states the product is non-returnable and manufactured in Liberty, Missouri, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.